To include your compound in the COVID-19 Resource Center, submit it here.

GLYC-101: Final Phase II data

Final data from a double-blind, U.S. Phase II trial in 26 patients undergoing carbon dioxide laser skin

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE